» Articles » PMID: 32005980

Host-microbiota Interactions in Inflammatory Bowel Disease

Overview
Journal Nat Rev Immunol
Date 2020 Feb 2
PMID 32005980
Citations 278
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian intestine is colonized by trillions of microorganisms that have co-evolved with the host in a symbiotic relationship. The presence of large numbers of symbionts near the epithelial surface of the intestine poses an enormous challenge to the host because it must avoid the activation of harmful inflammatory responses to the microorganisms while preserving its ability to mount robust immune responses to invading pathogens. In patients with inflammatory bowel disease, there is a breakdown of the multiple strategies that the immune system has evolved to promote the separation between symbiotic microorganisms and the intestinal epithelium and the effective killing of penetrant microorganisms, while suppressing the activation of inappropriate T cell responses to resident microorganisms. Understanding the complex interactions between intestinal microorganisms and the host may provide crucial insight into the pathogenesis of inflammatory bowel disease as well as new avenues to prevent and treat the disease.

Citing Articles

Probiotic nanocomposite materials with excellent resistance, inflammatory targeting, and multiple efficacies for enhanced treatment of colitis in mice.

Huang Y, Cai H, Liu H, Wang L, Feng G, Ding Z J Nanobiotechnology. 2025; 23(1):188.

PMID: 40055678 PMC: 11889847. DOI: 10.1186/s12951-025-03240-1.


Culture-based characterization of gut microbiota in inflammatory bowel disease.

Park H, Yeo S, Lee T, Han Y, Ryu C, Huh C Front Microbiol. 2025; 16:1538620.

PMID: 40051478 PMC: 11884817. DOI: 10.3389/fmicb.2025.1538620.


Transcriptomics and microbiome insights reveal the protective mechanism of mulberry-derived postbiotics against inflammation in LPS-induced mice.

Abbas Z, Tong Y, Zhang J, Sammad A, Wang J, Ahmad B Front Immunol. 2025; 16:1536694.

PMID: 40040706 PMC: 11876837. DOI: 10.3389/fimmu.2025.1536694.


Causal association between gastroesophageal reflux disease and sepsis, and the mediating role of gut bacterial abundance, a Mendelian randomization study.

Fu Z, Jiang Z, Zhao F, Gou T, Jiang L Medicine (Baltimore). 2025; 104(8):e41631.

PMID: 39993106 PMC: 11857025. DOI: 10.1097/MD.0000000000041631.


Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment.

Ali A, Zahran S, Eissa M, Kashef M, Ali A Gut Pathog. 2025; 17(1):10.

PMID: 39966979 PMC: 11834511. DOI: 10.1186/s13099-025-00683-7.


References
1.
Kaplan G . The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015; 12(12):720-7. DOI: 10.1038/nrgastro.2015.150. View

2.
Xavier R, Podolsky D . Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. DOI: 10.1038/nature06005. View

3.
Liu J, van Sommeren S, Huang H, Ng S, Alberts R, Takahashi A . Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47(9):979-986. PMC: 4881818. DOI: 10.1038/ng.3359. View

4.
McGovern D, Kugathasan S, Cho J . Genetics of Inflammatory Bowel Diseases. Gastroenterology. 2015; 149(5):1163-1176.e2. PMC: 4915781. DOI: 10.1053/j.gastro.2015.08.001. View

5.
Pickard J, Zeng M, Caruso R, Nunez G . Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017; 279(1):70-89. PMC: 5657496. DOI: 10.1111/imr.12567. View